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This investigation was conducted to study the effects of acet-
aminophen on sulfur constituents in livers of rats fed various diets 
differing in respect to inorganic sulfate and methionine. Sodium 35so4= 
was administered to label ester sulfates, 35s-cysteine to label ester 
sulfates and neutral sulfur compounds other than methionine and 35s-
methionine to label ester sulfates and neutral sulfur and by a precursor 
relationship give an indication of the effect acetaminophen may have on 
the remethylation pathway. Times of isotope injections were varied so 
that i miiled i ate synthesis of sulfur compounds could be evaluated as ~.ie 11 
as the effect the drug may have on tissue levels of sulfur compounds. 
Results from this investigation demonstrate that: (1) in acetaminophen-
treated rats, liver sulfate is lowered to some constant level at which sul-
fate conjugation becomes rate limiting; (2) methionine is possibly drawn 
out of the remethylation pathway for synthesis of glutathione and cysteine; 
(3) inorganic sulfate may spare cysteine and possibly has the potential 
to inhibit the conversion of methionine to cysteine; and (4) inorganic 
sulfate fed at the 0.02% level with methionine supplementation is the 
optimal level which allows the liver to pull cysteine to glutathione 
for detoxication of acetaminophen. This investigation demonstrated the 
need for dietary inorganic sulfate as well as sulfur amino acids for 
acetaminophen detoxication, and that dietary levels of inorganic sulfate 
can inhibit or enhance the effect exerted by the drug depending on the 
level of inorganic sulfate and methionine. 
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CHAPTER I 
INTRODUCTION 
Sulfur should be present in the diet of many organisms in the 
form of organic as well as inorganic compounds. The importance of inor-
ganic sulfur as a dietary constituent has been demonstrated in the labo-
ratories of the r~utrition and Food Sciences Department, The University 
of Tennessee at Knoxville, in the areas of carbohydrate, fat, and pro-
tein metabolism as well as for detoxication (1). Organic sulfur in the 
forms of glutathione, cysteine, and methionine are involved in many 
physiological processes, but is especially important for the detoxica-
tion of xenobiotics such as acetaminophen. 
Acetaminophen is a common, widely used analgesic that is a compo-
nent of many over-the-counter preparations. Atetaminophen has been 
shown to be hepatotoxic to those who are frequent users, those who have 
a history of liver disease, as well as those who have tried suicide by 
its ingestion. The drug's metabolism--although complex--requires inor-
ganic sulfate as well as organic sulfur. Inorganic sulfate is mainly 
used for sulfation while the sulfur nucleophile glutathione (cysteine 
and methionine sulfur can be incorporated into glutathione) conjugates 
the toxic metabolite which is generated through the cytochrome P-450 
system. This toxic metabolite, if not cleared, results in liver necro-
sis. Not only is there a relationship between cysteine, methionine, and 
glutathione, but cysteine can be the sulfur source for inorganic 
sulfate. 
Little information is available concerning the intricacies 
dietary inorganic sulfate and methionine supplementation may have on 
acetaminophen detoxication. It is the purpose of this investigation to 
provide evidence that dietary manipulation, through varying levels of 
inorganic sulfate and methionine, will be able to alter the rat's abil-
ity to detoxify acetaminophen given as a pulse dose. 
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CHAPTER II 
REVIEW OF LITERATURE 
I. IMPORTANCE OF INORGANIC SULFATE 
In the Monogastric Animal 
Research has clarified the importance of inorganic sulfate to 
the nutrition of the monogastric animal, particularly in reference to 
carbohydrate, fat, and protein metabolism; drug detoxication; and tissue 
integrity (1). Wellers et al. (2) showed that inorganic sulfur in the 
aiet could supply about one-third of the sulfur required beyond that of 
amino acids. Fulton and Smith observed that rats fed diets with vari-
able sulfate/sulfur ratios sho\,ed different responses to avitaminosis E 
and that vitamin E deficient rats appeared to be less effective in con-
verting 35s-cysteine to 35sulfate than vitamin E sufficient rats (3). 
In studying the utilization of calcium and sodium sulfate by the rat, 
Button et al. (4) demonstrated that dietary inorganic sulfate was well 
absorbed and utilized for the formation of mucopolysaccharides. Michels 
and Smith (5) showed that, unless the requirement for sulfur-containing 
amino acids is to be increased, the diet must contain a minimal amount 
of inorganic sulfur. Brown and Gamatero (6) showed that addition of 
inorganic s~lfur to the diets of rats fed an inadeq~ate protein source 
low in sulfur containing amino acids improves net weight gain, feed:gain 
ratios, and protein efficiency ratios. 
Researchers have shown that a lack of inorganic sulfate in the 
diet forces the rat to satisfy its sulfate requirements by the oxidation 
3 
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of cysteine to sulfate, which is a wasteful process. Whittle and Smith 
(7) demonstrated that rats fed diets low in inorganic sulfur excrete 
twice as much cysteine sulfur as taurine sulfur compared with those 
animals fed diets high in inorganic sulfur. This observation agrees 
with that of Michels and Smith (5) that diets low in inorganic sulfur 
appear to raise the methionine requirement of the rat. Although the 
increased excretion of taurine may not be harmful, other deleterious 
effects appear to be associated with forcing a rat to supply its sulfate 
needs by oxidation of cysteine sulfur. For example, Fulton and Smith (3) 
demonstrated that avitaminosis E reduced the incorporation of 35s-sulfate 
by cellular lipoprotein and by the sulfolipid and mucopolysaccharide 
fractions associated with the lipoprotein. From the work of Brown et 
al. (8) it is demonstrated that a decrease occurs in the breaking 
strength of the aorta of rats fed diets low in sulfate. In addition, 
when rats from mothers fed a low-sulfate diet were transferred to a low 
sulfate diet without cod-liver oil, gross malformation of the hind limbs 
was seen (1). 
Smith has established the optimal level of inorganic sulfate in 
the diet of a rat to be 0.02% (9). Smith and his coworkers also have 
shown that dietary sulfate levels both above ana helow this opti~al 
level result in changes in glycogen storage, and in the activity of rat 
liver phosphoenolpyruvate-carboxykinase, pyruvate carboxylase, 1 changes in 
the activity of propionyl-CoA carboxylase, 2 acetyl-CoA carboxylase, citrate 
1Feland, B., Disney, G. W. & Smith, J. T. (1973) Dietary sulfate 
as a metabolic regulator. Fed. Proc. 32:883. 
2white, V. & Smith, J. T. (1575) Effects of inorganic sulfate on 
propionyl-CoA carboxylase. Am. Chem. Soc. Southeast Regional Me2ting 
1:225. 
5 
cleavage enzyme, malic enzyme, 3 glutamyl transferase, 4 coenzyme A con-
h 
centration,~ the number of lung lesions formed from intratracheal 
instillation of benzo(a)pyrene, 6 and the ratio of salicylarnide:sulfate 
excreted in the urine. 7 
Following the work of Wnit~le and Smith (7) the effect of dietary 
inorganic sulfur on the relative concentration of taurocholic and gly-
cocholic acids in the s~all intestine was measured. Earlier investiga-
tors (10) had shown that in man the glycocholic:taurocholic acid ratio 
is a reflection of the availability of taurine. Therefore, based on 
Wnittle's and Smith's data, those rats fed the diet containing 0.0002% 
sulfate should have had the smallest intestinal glycocholic:taurocholic 
ratio. However, those rats fed the diet containing 0. 1% sulfate had a 
significantly lower glycocnolic:taurocholic ratio than those fed diets 
either low or high in sulfate. Since a low glycocholic:taurocholic 
ratio is generally correlated with low serum cholesterol levels, serum 
3Bittle, J. B. & Smith, J. T. (1975) Effect of dietary inorganic 
sulfate on selected enzymes of lipogenesis in the rat. Fed. Proc. 
36:1114. 
4Nielson, R. L. & Smith, J. T. (1975) Effect of dietary sulfur on 
glutathione concentration and y-glutamyl transferase activity in the rat 
brain. Fed. Proc. 37:752. 
5Smith, J. T. & Verma, R. S. (1974) Relative conjugation of Qlycine 
and taurine with cholic acid by rat liver microsome preparation. rea. 
Proc. 33:689. 
6settle, E. A. (1977) An investigation of the relationship between 
sulfur nutritional status and lung neoplas~s induced by oenzo(a)µyrene 
in rats. Unpublished Ph.D. dissertation, The University of Tennessee, 
Knoxville. 
7 Kurzynske, J. S. & Smith, J. T. (1975) A relationship between the 
dietary history of a rat and the relative conjugation of glucuronate and 
sulfate with salicylamide. Fed. Proc. 34:882. 
6 
cholesterol levels and blood glucose levels nave been detercined in rats 
fed these diets with different inorganic sulfate levels and different 
levels of cysteine supplementation. The glycocholic:taurocholic acid 
ratio, serum cholesterol, and blood glucose levels were interrelated and 
related to the sulfur nutritional status in the rat (ll). 
In Drug Metabolism 
Inorganic sulfate has also been shown to have a role in drug 
detoxication. Roe (12) demonstrated that indole-fed rats could use 
inorganic sulfate as an efficient source of sulfate ions for indican 
formation. Moldeus et al. (13) showed that sulfate conjugation of 
harmol and acetaminophen in isolated hepatocytes was highly dependent on 
extracellular so4-. Weitering et al. (14), by measuring the sulfate and 
glucuronide conjugates in vivo, studied the depletion of the inorganic 
sulfate pool in rats after administration of phenol. Data indicated 
that with increased dose of phenol its glucuronidation increases rela-
tive to its sulfation but that this switch over is not due to a rate 
limiting supply of inorganic sulfate for sulfotransferases but perhaps 
to a higher Km for the for~ation of 3'phosphoade~osine-5'-phosp~osulfate 
(PAPS). Slattery and Levy (15) were able to demonstrate that Na 2so4 
significantly decreased the Lo 50 of acetaminophen relative to that with 
NaCl administration. 
In conclusion the inorganic sulfur status is important in carbo-
hydrate, fat, and protein metabolism; tissue integrity; and drug detoxi-
cation in the monogastric animal. 
II. METABOLISM OF ACETAMINOPHEN 
Acetaminophen, widely used as an antipyretic and analgesic, is 
found in over 200 formulas (e.g., Tylenol, Comtrex, Excedrin, Nyquil, 
Vanquish). Under normal therapeutic doses acetaminophen is primarily 
metabolized by conjugation with glucuronide or sulfate with a plasma 
7 
half life range of 1-3 hours (16). Sulfate conjugation is the preferred 
route of metabolism but as the dose and concentration of the drug 
increase so does the formation of a glutathione (GSH) conjugate (17, 
18, 19). Early evidence by Jollow and his coworkers indicates that when 
the GSH pools are 80% or more depleted a toxic metabolite is formed via 
the microsomal P-450 mixed function oxidase system; this metabolite 
combines with liver microsomal proteins and causes necrosis (20, 21, 22). 
More recent research indicates that the toxic ~etabolite is N-acetyl-p-
quinoneimine (23, 24). An overview of acetaminophen metabolism can be 
seen in fig. l (25). Although ~any believe that necrosis results from 
the binding of a toxic metabolite to liver protein, others feel that 
necrosis is a result of lipid peroxidation (26, 27). 
Acetaminophen is passively absorbed from the gastrointestinal 
tract (28). Heading et al. demonstrated that the rate of gastric 
emptying influenced plasma concentration and urinary excretion (29). 
Acetaminophen ingestion also has been associated with nephropathy 
(1, 30). Acetaminophen is metabolized primarily by the liver but the 
kidney does convert the GSH conjugate to the mercapturic acid deriva-
tive (31). Porter et al. (32) showed that acetaminophen slowed mito-
chonarial respiration by inhibiting electron transport between NADH 
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Fig 1. Metabolism of acetamlnophen.1 
1 
Wolff, M. ed. ( 1980) Burger's Medic al Chemistry. 
Part 1. The Basis of Medicinal Chemistry. 4th 
ed. John WIiey & Sona, New Vork. 
8 
kidney cells are different from tnose for liver cells in that the 
y-glutamyl cycle functions in the kidney (33). 
9 
Glutathione synthesis, concentration, and availability are major 
factors or concerns in acetaminophen metabolism and will be diagramed 
later. Higashi et al. (34) suggest that there might be two GSH pools 
but Lauterburg's recent probe analysis technique discredits this inter-
pretation (35). 
The toxic metabolite is believed to be generated through the 
P-450 mixed function oxidase system (36). Therefore, any drug or proce-
dure that influences this system also has the potential to affect the 
metabolism or efficacy of acetaminophen. Acetaminophen, although a 
structurally simple compound, possesses a multifaceted metabolic pathway. 
III. SULFUR METABOLISM IN RELATION TO 
ACETAMINOPHEN DETOXICATION 
Smith (l) offers a schematic representation of the metabolic 
pathways leading to the formation of sulfate from the sulfur-containing 
amino acids methionine, cysteine, and cystine. Since in low doses 
acetaminophen is sulfated it is important to understand the formation of 
PAPS. At higher doses of acetaminophen an active metabolite is conju-
gated by GSH and when GSH is depleted necrosis will result. It is 
therefore important to understand metabolism and sulfur sources of 
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constituent for the monogastrlc animal. Bulletin 571. 
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Researchers in different disciplines have been searching for 
clues to the biochemical mechanisms involved in the metabolism of 
acetaminophen, the mechanism(s) of liver necrosis, and the management 
of acetaminophen in therapeutic and toxic doses. As outlined in the 
previous section the metabolism of acetaminophen is complicated, but it 
is generally conceded that necrosis results from the microsomal cyto-
chrome P-450 mediated oxidation of the analgesic which becomes bound to 
~icrosomal liver protein when GSH pools are depleted (16, 37). 
Morphological Changes in the Liver 
The biochemistry of acetaminophen-induced hepatotoxicity has been 
extensively investigated but the exact mechanisms of cell necrosis have 
not been elucidated. Dixon et al. (38) working with rats killed at differ-
ent times after toxic doses, summarize the events of hepatotoxicity as 
follows: hydopic vaculation, centrilobular necrosis, macrophage infil-
tration, and regenerative activity with rapid restoration to normal. 
Studying the morphology of acetaminophen induced necrosis has led some 
investigators to suggest the toxicity to be a result of structural 
damage to the endoplasmic reticulum as manifested by lipoperoxidation 
and reduced activities of microsomal enzymes (39). Recently, Walker 
and his colleagues embarked on a detailed electron microscopy study and 
discussion of acetaminophen induced hepatotoxicity (40). 
Factors Affecting Acetaminophen Metabolism 
There can be many factors that can inhibit or induce the action 
of acetaminophen. Different rates of metabolism or toxicity can be 
13 
observed with respect to: age, propylthiouracil (PTU)-induced hypothy-
roidism, diabetes, ascorbic acid, previous liver status, fasting, and 
drugs. 
The variable of age and its effect on acetaminophen metabolism 
and hepatotoxicity has been documented in rats, mice, and humans. 
Peterson and Rumack (41) report that of among 416 patients studied, the 
16 children under five years of age had a relatively low incidence of 
toxicity as compared with the adult group. This could be attributed 
to a change from predominantly sulfate to glucuronide metabolism, and/ 
or an immature P-450 system to make the reactive metabolite (42, 43). 
The Levy et al. study indicated that neonates were able to metabolize 
acetaminophen well because a limited ability to conjugate the drug with 
glucuronic acid was compensated by sulfate conjugation (44). Several 
investigators tested the hyµothesis that young mice or rats are less 
susceptible to acetaminophen overdoses than older animals (45, 46). 
Results from these studies indicate less covalent binding of acetamino-
phen to liver protein, less hepatic GSH depletion, and less hepatic 
necrosis in young than in adult animals. The reason given for this 
phenomenon is that the young animals have an immature hepatic mixed 
function oxidase system which would theoretically reduce the amount of 
toxic metabolite formed. The data of Alhava et al. are not in agreement 
with the other research results outlined, but this could be due to 
different strains and species of animals (47,22). 
Linscheeret al. proposed that PTU-induced hypothyroidism would 
protect against acetaminophen toxicity; the proposal was based on evi-
dence that hypothyroidism increases red cell glutathione levels and PTU 
may act as a substrate for GSH (48). Their blood evaluation and 
electron microscopy revealed less toxicity, probably because of 
increased GSH levels or increased glucuronidation of acetaminophen. 
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Another endocrine disorder that alters acetaminophen metabolism 
is diabetes (49). Research with streptozotocin diabetic rats indicates 
that the diabetic rats are more susceptible for acetaminophen to deplete 
GSH levels than controls. 
Ascorbic acid is partly converted to ascorbic acid sulfate in 
humans (50). This finding induced Houston and Levy to determine whether 
3 g of ascorbic acid would have an effect on the metabolism of l g 
acetaminophen in male volunteers (51 ). Results indicated that ascorbic 
acid caused a significant decrease in the fraction of acetaminophen 
excreted as sulfate and increased the fraction excreted as glucuronide 
but had no effect on the recovery of total acetaminophen. After the 
administration of ascorbic acid there was a decreased excretion rate 
of acetaminophen; the decrease could be inhibited by sodium sulfate but 
not L-cysteine. The authors suggest that individuals ingesting mega-
doses of vitamin C while on acetaminophen therapy should be evaluated 
for susceptibility to liver necrosis, especially if there already exists 
some liver condition. 
Animal and human research indicates that a liver is more suscep-
tible to hepatotoxicity if there is an existing liver condition or 
chronic alcohol consumption (52, 53, 54). Another study with rats 
revealed that a single dose of ethanol protects against acetaminophen 
hepatotoxicity (55). A case study reported by Bonkowsky et al. 
describes chronic hepatic necrosis in a 53-year-old man who had taken 
4 g of acetaminophen a day for l year (56). 
There have been numerous reports concerning the effects of 
fasting, different diets, and drug therapy, alone and in combination, 
l 5 
on acetaminophen toxicity and metabolism (57, 58). Jaffe et al. 
studied acetaminophen absorption in man and found that neither a high 
lipid content, high protein content, or a balanced meal had any effect 
on the drug's excretion but fasting did result in higher excretion 
values (59). Other researchers have demonstrated that fasting will 
increase hepatotoxicity due to decreasing GSH levels (60, 61.). Work 
with the effect of other drugs given simultaneously with acetaminophen 
showed an increased hepatotoxicity, with some drugs depleting GSH levels 
or sulfate levels or inducing the mixed function oxidase system (62, 63, 
64). In summary, there are many factors in acetaminophen administration 
that have the potential to alter, inhibit, or induce the metabolism and 
hepatotoxicity of acetaminophen. 
Treatment of Hepatotoxicity 
Davidson and Eastham reported the first case of acetaminophen 
induced hepatic necrosis in humans in 1966, 70 years after the drug's 
introduction (65). Because of its accessibility and popularity, the 
United Kingdom and the United States have had to deal with the problem 
of treating hepatotoxicity mainly as a consequence of suicide attempts. 
Treat@ents have included attempts to reduce the gastrointestinal tract's 
absorption of the drug by the administration of charcoal or cholestyra-
mine, enhance removal from plasma by hernodialysis, or by charcoal hemo-
perfusion; however, none of these methods seemed adequate (16). 
In approaching the problem of treating hepatotoxicity, research-
ers have looked at it in terms of providing chemical sources which act 
16 
as surrogate glutathione or inhibit the cytochrome P-450 mixed function 
oxidase enzymes. A closer look at these two avenues of research reveals 
conflicting, even confusing data. 
For example, N-acetyl cysteine is considered the antidote of 
choice (16, 66, 67); it possibly acts to replenish glutathione but the 
mechanism has not been proven. Whitehouse et al. claims that N-acetyl 
cysteine inhibits gastric emptying (68). Vina et al. claim that large 
doses of N-acetyl cysteine decrease hepatic GSH levels while still 
protecting against hepatotoxicity; others just report that it works but 
they do not offer any explanations for their data (69, 70, 71 ). 
McLean and Day showed that adding 10% methionine to their low 
protein and/or phenobarbital treated rats would protect against hepato-
toxicity by supplying the needed glutathione (72). Buckpitt et al. 
investigated the effect of glutathione, cysteine, N-acetyl cysteine, 
cysteamine, cr-mercaptopropionylglycine, and methionine on the NADPH-
dependent metabolism and on covalent binding of acetaminophen. They 
concluded that methionine did not affect the covalent binding of acet-
aminophen (73). This is in agreement with Labadarios et al. who suggest 
that cr-mercaptopropionylg1ycine administration decreases hepatotoxicity 
but not by binding the toxic metabolite itself. Rather, a-mercaptopro-
pionylglycine acts like GSH (74). 
Since the metabolism of large doses of acetaminophen involves a 
P-450 mediated toxic metabolite that binds to liver macromolecules and 
causes necrosis, some investigators have thought of the possibility of 
treating toxicity by inhibiting P-450 enzymes. Metyrapone tartate 
administered i.p. 400 mg/kg raised the Lo 50 for acetaminophen from 
340 mg/kg i.p. to 540 mg/kg in fasted white mice (57 ). As previously 
l 7 
mentioned, it has been shown that a single dose of ethanol (l g/kg) pro-
tects against hepatotoxicity in white mice presumably by depressing 
P-450 levels (55). Another study indicating that the depression of 
P-450 levels can decrease hepatotoxicity of acetaminophen is that of 
Strubelt et al. demonstrating that pretreatment with acetaminophen pro-
duces complete protection against further doses of acetaminophen (75). 
The purpose of this investigation was to offer some insight into 
the effect of acetaminophen and various levels of inorganic sulfate with 
methionine supplementation on tissue levels and stores of ester sulfates 
and neutral sulfur compounds. This investigation was also an attempt 
to provide information concerning the effect of acetaminophen and vari-
ous levels of inorganic sulfur varying in methionine supplementation on 
the remethylation pathway. 
CHAPTER III 
EXPERIMENTAL PROCEDURE AND METHODS 
Rationale for Experimental Design 
There are many factors that have the potential to alter, inhibit, 
or induce the metabolism and hepatotoxicity of acetaminophen as dis-
cussed in Chapter l. Sprague Dawley male rats were chosen for this 
investigation because of their use in many of the studies discussed. 
Age and maturity were controlled through the use of animals of 150-190 g. 
However, in experiments l and 2, a limited supply of animals dictated 
the use of 250-400 g rats. 
Several routes of administration were investigated in the studies 
described, but the stomach tube was chosen as the best method to mimic 
normal therapeutic use. Rats were fed up to the point of sacrifice in 
order to avoid a fasting effect on results. A low dosage was chosen in 
order to mimic conditions that would be more representative of a thera-
peutic dose. Experiments l, 3, and 5 were designed to study the effects 
of acetaminophen on the liver's immediate sulfur metabolism; experi~ents 
2, 4, and 6 were designed with a longer wait between injections of the 
labeled sulfur source and killing in order to study the effect of the 
detoxication of acetaminophen on tissue stores. 
Groups of 30 male Sprague-Dawley rats were fed casein based semi-
purified diets containing either 0.0002%, 0.02% or 0.42% inorganic 
sulfate. The diets containing 0.0002% and 0.02% were supplemented with 
methionine to provide constant sulfur while the 0.42% diet had no 
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2Nutrition Biochemicals Corporation, Cleveland, Ohio 44128. 
= 
Vitamin Diet Fortification Mixture formulated to supply the following 
amounts of vitamins (g/kg vitamin premix): thiamin hydrochloride 1.0, 
riboflavin 1 .0, niacin 4.5, p-aminobenzoic acid 5.0, calcium pantothe-
nate 3.0, pyridoxine hydrochloride 1 .0, ascorbic acid 45.0, inositol 5.0, 
choline chloride 75.0, menadione 2.25, biotin 0.020, folic acid 0.090, 
vitamin ~12 0.00135, ~-tocopherol 5.0, vitamin A 9 x 105 units, vitamin D 1 x 10 units, and sufficient glucose to make 1 kg. 
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TABLE 2 
Composition of salt mix 
Component Quantity per 500 g 
g 
MgC03 33.700 
NaCl 77. 400 
KCl 125.400 
KHl04 237.800 
FeP04 · 2(H20) or (FeC6H5o7) 23.000 
KI 0 .090 
NaF 0. l 00 
MnC1 2 · 4H 20 0 .450 
AlK·S04 · 12 H20 0. 019 
Cu(C2H3o2)2 · H 0 2 0.810 
ZnC03 4.800 
21 
in stainless steel group cages and fed these diets and distilled water 
ad lib. for 17 days. The radioactive sulfur source was dissolved in 
saline so that each 0.5 ml contained 7 µCi. ~ach rat was given 0.5 ml 
of the radioactive saline solutions. c. The drug was prepared by dis-
solving 75 mg acetaminophen/kg body weight in 5 ml of corn oil and 
administered by stomach tube. Control animals were treated with the 
labeled sulfur source and corn oil without acetaminophen. 
Experiment l 
To assess the effect of diet and acetaminophen on the synthesis 
35 = of ester sulfate compounds, rats were simultaneously given Na2 so4 
and acetaminophen. After the injections, the rats were housed in spe-
cial isolated cages for radioactive animals and given their respective 
diets and distilled water ad lib. Three hours after the injections 
the rats were decapitated and the livers were excised, placed in tared 
vials, weighed, and stored at -20°c until analysis. 
To prepare the livers for determination of radioactivity and 
total sulfur analysis, the livers were lyophilized in a Virtis freeze 
dryer. The freeze-dried livers were pulverized with a stainless steel 
spatula. 
To determine specific activity duplicate 500-600 mg samples were 
weighed and combusted in a Parr Bomb with 10 ml distilled water. The 
aqueous ash from each was transferred to a beaker whereupon the bomb con-
tainer was rinsed with distilled water and contents emptied into the beaker 
several times. The aqueous ash extract was evaporated to dryness and 
2 ml of distilled water were added. Two 0.5 ml samples were pipetted 
into scintillation vials to which 6 ml 2-ethoxyethanol and 10 ml of 
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2,5-diphenyloxazole (12 gin l liter toluene) were added. Radioactivity 
was evaluated with a Beckman LS lOOC liquid scintillation system. The 
data were expressed as cpm/mg, cpm/mg. body weight, cpm/mg f dry liver 
weight as% dose, total cpm as% dose. wet liver weight. 
For total sulfur analysis 500-600 mg liver samples were combusted 
in the Parr Bomb with 10 ml distilled water. The aqueous ash from each 
sample was transferred quantitatively to a 25 ml volumetric flask and 
made to volume with distilled water. Portions of the dilute ash were 
analyzed in duplicate for total sulfur by a method described by Roe (76). 
A standard stock solution was made by dissolving 1.479 g of sodi-
um sulfate in 500 ml of distilled water which yielded a concentration of 
2000 ppm of sulfate. Al ml portion of dilute ash was added to a 50 ml 
conical Pyrex centrifuge tube and l ml of 5% lanthanum chloride and 2 ml 
of 15% barium chloride~were pipetted into each, sample. A standard was 
prepared with each sample set by mixing 0.25 ~, of the standard stock 
solution with 0.75 ml distilled water, l ml of lanthanum chloride, and 
2 ml of 15% barium chloride. The samples were mixed with a Vortex mixer 
and centrifuged at 2000 x g for 10 minutes in an International Harvester 
Model SBV centrifuge. The supernatant was decanted and the centrifuge 
tubes were carefully dried with tissues to remove residual water. Five 
ml of distilled water were added to each precipitate, mixed, centrifuged, 
and supernatant discarded. After two additional washings the centrifuge 
tubes were drained and dried and 10 ml of an alkaline disodium ethylene-
diamine solution (prepared by dissolving 10 g EDTA in 500 ml of distilled 
water, adding 20 g of sodium hydroxide and diluting to 2000 ml) were 
added. Each sample was mixed thoroughly with a Vortex mixer. 
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Samples and standards were aspirated into the fla~e of a Perkin 
Elmer Model 303 Atomic Absorption Spectrophotometer equipped with a 
barium hollow cathode tube operated at 20 milliamps. The instrument 
settings were: monochro~eter, 276 nm visible; gain, 5 to 6; slit, 3; 
flow rate of nitrous oxide, 8.5; flow rate of acetylene, slightly above 
15. The nitrous oxide burner was ignited and the fuel flow was adjusted 
to give a characteristic magenta cone. Percent absorption was recorded 
and later converted to absorbance so that the µg sulfate per mg liver tissue 
of mg combusted samples could be calculated by the following equations: 
a) 
Absorbance of unknown Concentration Dilution 
Absorbance of standard x Standard (ppm)x Dry weight of liver 
= µg Sas so4-; liver 
b) Absorbance of unknown Concentration Dilution Absorbance of standard x Standard (ppm) x g liver sample= 
µg Sas so4-; g tissue 
The burner and aspiration assembly were cleaned after every 24 readings 
to insure accuracy. 
Experiment 2 
This experiment was designed to measure the effect of diet on 
35 detoxication of acetaminophen and on tissue stores of Na2 so4 labeled 
sulfur sources. Experiment 2 differed from experiment l in that 
Na2
35so4 was given 24 hours prior to acetaminophen administration. The 
methods of analysis were the same as in experiment 1. 
Experiment 3 
This experiment was designed to measure the effect of diet and 
drug detoxication on synthesis and/or utilization of ester sulfate com-
pounds and neutral sulfur compounds (glutathione, cysteine) and to 
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elucidate mechanisms in the methionine remethylation pathway. Labeled 
35s-methionine was injected simultaneously with acetaminophen; 3 hours 
later the rats were sacrificed and livers were excised and placed in 
20 ml 2% sulfosalycilic acid. The livers were blenderized and centri-
fuged at 5000 x g for 15 minutes. The supernate fluid was saved and 
into each sample l ml each of glutathione, cysteine, and methionine was 
pipetted to enable the recovery of the radioactive sulfur compounds. 
The glutathione and cysteine solutions were made by dissolving sepa-
rately in 10 ml volumetric flasks, 200 mg reduced glutathione and 
cysteine. Methionine was prepared in the same manner except that it 
was dissolved with 0.02 N HCl instead of distilled water. 
Following an adapted method of Mimura et al. (77) the solution 
was eluted through a 45 x 2.5 cm Dowex-50 column first with 200 ml of 
water then 200 ml of 0.05 N HCl. After these solutions were eluted 
l N HCl was added to the column. By testing the eluate from the column 
with a platinic iodide solution the presence of sulfur containing com-
pounds could be detected. Elution of glutathione and cysteine from the 
column required approximately 400 and 600 ml respectively of l N HCl 
solution. Elution of methionine required approximately 200 ml of 2N 
HCl. These three different compounds were collected in beakers and 
evaporated to dryness. Earlier testing with paper chromatography tech-
niques revealed the relative purity of each of these compounds (78). 
After evaporation to dryness 5 ml of distilled water were added 
to each beaker. Two 0.5 ml samples were used for counting in the 
scintillation counter while two l ml samples were pipetted into 25 ml 
Erlenmeyer flasks for titration against a platinic iodide solution. 
The platinic iodide solution was prepared by combining 0.8 ml 10% 
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platinum chloride, 124.2 ml distilled water, and 25 ml 6% potassium 
iodide. A titer for glutathione, cysteine, and methionine was deter-
mined after taking 0.1, 0.3, 0.5, and 0.7 ml of a solution of 200 mg of 
the compound dissolved in 10 ml of distilled water--except in the case 
of methionine where it was dissolved and brought up to volume with 0.02 
N HCl. 
Data were expressed in terms of% dose, % dose+ liver weight, 
and% dose+ body weight for each 35s-sulfur compound recovered. 
Experiment 4 
This experiment was designed to measure the effect of diet and 
drug detoxication on tissue utilization of ester sulfates and neutral 
sulfur compounds and the effect on the methionine remethylation pathway 
with the injection of 35s-methionine. Experiment 4 differed from 
experiment 3 in that acetaminophen was administered three hours after 
35s-methionine. Three hours after acetaminophen administration the 
animals were sacrificed and the same procedure and analysis as described 
for experiment 3 were performed. 
Experiment 5 
To determine the effect of diet and drug detoxication on the 
synthesis of sulfur compounds, 35s-cysteine was given simultaneously 
with acetaminophen to label ester sulfate and neutral sulfur compounds 
other than methionine. Rats were sacrificed three hours after the 
injections and the same procedure as described for experiment 3 was 
performed except that methionine was neither added to the liver 
solution or collected. 
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Experiment 6 
This experiment was designed to measure the effect of diet and 
acetaminophen detoxication on tissue synthesis of ester sulfates and 
35 · neutral sulfur when given a S-cysteine source. This experiment dif-
fered from experiment 5 in that acetaminophen was administered three 
hours after 35s-cysteine. Three hours after acetaminophen was adminis-
tered the rats were sacrificed and the same procedure as in experiment 3 
was performed. 
Statistical Methods 
Data were analyzed to determine the statistical significance of 




Experiment l: Rats Injected with 35so4= Si~ultaneously with Acetamino-phen Administration 
The data showing the interrelationship among dietary inorganic 
sulfate, varying levels of methionine, acetaminophen administration, and 
total sulfur as sulfate content of rat liver as% body weight are seen 
in Table 3. A statistically significant difference in total liver sul-
fur as sulfate was observed between control rats fed diets containing 
0.0002% inorganic sulfate supplemented with methionine and livers from 
rats fed 0.42% inorganic sulfate without additional methionine--the latter 
having the lower value. There was no detected difference among acetaminophen-
treated rats fed the various diets. The effect of acetaminophen in 
lowering total liver sulfur as sulfate was statistically signficant 
with diets containing the 0.0002% and 0.02% inorganic sulfate with 
methionine supplementation but not when compared to the rats fed the 
diet containing 0.42% inorganic sulfate with no additional methionine. 
Although the contrcl group fed the 0.42% inorganic sulfate without additional 
methionine did not have a statistically significant difference in total 
liver sulfur as sulfate when compared to the acetaminophen-treated 
group, it did have a higher total sulfur as sulfate content in the liver. 
Wh d t d · f t 35s d. t. . t ( T bl en a a are expresse ,n re erence o -ra ,oac ,v, y a es 
4 and 5) the dietary level of inorganic sulfate did not affect the 
values regardless of acetaminophen administration or when expressed as 
cpm/mg, cpm/mg + body weight, cpm/mg x dry liver weight, and total cpm + 
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TABLE 3 
An interrelationship between dietary inorganic sulfate, 
acetaminophen administration, and the sulfate content 
of rat liver (Experiment l) 
Dietary 
Sulfate% 
.0002 (Diet A) 
.02 (Diet B) 
. 42 (Diet C) 
Total Liver Sulfate 
With Acetaminophen 
15.2 1.21,2,3, a* ± 
15. 8 ± l. l a* 
15. 3 ± 1.8 a* 
1oata are means± SEM of 5 male rats. 
as% Body Weight 
Without Acetaminophen 
X l0- 2 
31.9 ± 2.8a,b 
30. l ± l • 3 a' b 
b* 21.3 ± 1.9 
2values in a column not followed by the same superscript letter 
are significantly different (P : 0.05). 
3values on a line not followed by the same superscript symbol are 




The effect of dietary igorganic sulfate and acetaminophen administration on the 
total so 4= uptake in rat liver (Experiment l) 
35so4= Radioactivity in Dry Liver 
With Acetaminophenl Without Acetaminophen 
cpr.1/mg cpm/mg f body wt. cpm/mg cpm/mg f body ~~t. 
X 10-b X 10-5 
.0002 (Diet A) 37.8 ± 5.52,3,4 a* 24. l ± 12. 7 a * 
.02 (Diet B) 37.l ± 4.9 a * 9.7 ± 1.2 a * 
. 42 (Diet C) 29. 9 ± l. 8 a * 8.9 ± 0.9 a * 
1Acetaminophen and Na 235so4= administered simultaneously. 
2oata are means± SEM of 5 male rats. 
39. 8 ± 2. l a * 10.8 ± 1.4 a * 
51.3 ± 2.5 a * 14.4 ± 1.3 a * 
50.6 ± 8.4 a 14.9 ± 3.2 a * 
3column values for identical computations not followed by the same superscript letter are signifi-
cantly different (P < 0.05). 
4Line values for identical computations not followed by the same superscript symbol are signific-






The effect o~5die!ary inor~anic su~fate and acetaminophen adminis!ration on the total so4- uptake in rat liver expressed as% dose (Experiment l) 
With Acetaminophenl 
35 so11 = Rad_i_oact i vi ty in Dry Liver as Expressed By% Dose 
Without Acetaminophen 
cpm/mg x total cpm + cpm/mg x total cpm + 
dry liver v-1t. wet liver wt. 
X 10- l X 10-4 
dry liver wt. wet live
4
r wt. 
X 10-l X 10-
.0002 (Diet A) 
.02 (Diet B) 
. 42 (Diet C) 
11 . 2 ± l . 52' 3' 4 a * 
11 .3 ± 0.8 a * 
7.9± 0.3 a * 
9.8 ± 1.4 a * 
9.8 ± l .2 a * 
7.9 ± 0.4 a * 
1Acetarninophen and Na2
35so4= administered simultaneously. 
2Data are means± SEM of 5 male rats. 
12.6 ± 1.5 a* 10.5 ± 0.5 a* 
15.8 ± 1.8 a* 13.4 ± 1.3 a* 
14.2 ± 1.2 a 13.4 ± 2.0 a 
3column values for identical computations not followed by the same superscript letter are signifi-
cantly different (P < 0.05). 
4Line values for identical computations not followed by the same superscript symbol are signifi-




wet liver weight. There is a significant difference between the lower 
values for acetaminophen-treated rats and the higher values for control 
rats fed diets containing 0.42% inorganic sulfate with no methionine 
supplementation when data are expressed as cpm/mg x dry liver weight and 
total cpm + wet liver weight (Table 5). No differences are seen between 
diets in any of the data with respect to dietary levels of inorganic 
sulfate or methionine supplementation when data are expressed as cpm/mg, 
cpm/mg +bodyweight, cpm/mg x dry liver weight, and total cpm + wet 
liver weight. 
35 = Experiment 2: Rats Injected with so4 Twenty-Four Hours Prior to Acetaminophen Administration 
An interrelationship among dietary inorganic sulfate, methionine 
supplementation, and the sulfate content of rat liver can be seen in 
Table 6. The only effect of dietary sulfate as% body weight content is 
detected in acetaminophen administered rats fed a diet containing a 
0.02% inorganic sulfate with methionine compared to those rats fed a 
diet containing 0.42% inorganic sulfate with no additional methionine. 
A statistically significant difference in total sulfur as sulfate 
between the livers of rats administered acetaminophen and the control 
rats can be seen in only those rats fed the 0.02% level of inorganic 
sulfate with methionine supplementation; the livers from rats given 
acetaminophen had the higher total sulfur as sulfate content. 
Tables 7 and 8 present the data expressed in terms of 35so4= 
radioactivity. Control rats fed a diet containing 0.0002% inorganic 
35 = sulfate plus methionine have higher values of so4 than treated rats 
when expressed as: cpm/mg, cpm + body weight, cpm/mg x dry liver weight, 
and total cpm + wet liver weight. A statistically significant dietary 
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TABLE 6 
An interrelationship between dietary inorganic sulfate, 
acetaminophen administration, and the sulfate content 
of rat liver (Experiment 2) 
Dietary Total Liver ulfate as % Body Weight 
Sulfate% With Acetaminop en Without Acetaminop 
X 10- 2 X 10- 2 
1 _ 12,3,4,a b * 
* .0002 (Diet A) 19.8 ± 20.2 ± 1.2a 
.02 (Diet B) 22.8 ± 1.2 ab* 19.6 ± l. 2 a 
.42 (Diet C) 17. 3 ± l. 0 b* 19.4 ± 0.5 a 
l 35 = Acetaminophen administered 24 hours after Na2 so4 . 
2Data are means± SEM of 5 male rats. 
* 
3values in a column not followed by the same superscript letter 
are significantly different (P < 0.05). 
4values on a line not followed by the same superscript symbols 





The effect of dietary inorganic sulfate and acetaminophen administration on the 
total 35so4= uptake in rat liver (Experiment 2) 
With Acetaminophenl 
35so4= Radioactivity in Dry Liver 
Without Acetaminophen 
q.,m/mg cpm/mg f bgdy wt. 
X 10-
cpm/mg cpm/mg f body wt. 
X lQ-6 
.0002 (Diet A) 
.02 (Diet B) 
.42 (Diet C) 
9.8 ± l _82,3,4a* 
16.6 ± 3.8a* 
16. 2 ± l. 6 a* 
25.3 ± 5.0 b* 
44. 6 ± l . 6 a* 
44.2 ± 4.l ab* 
1Acetaminophen administered 24 hours after Na 2
35so4=. 
2Data are means± SEM of 5 male rats. 
15.2 ± 1.4 
17.l± 1.9 
15.l ± 3.3 
39.3 ± 4.0 a 
a* 45. 0 ± 5. 8 a* 
a* 40. 5 ± 9. 0 a* 
3column values for identical computations not followed by same superscript letter are significantly 
different (P < 0.05). 
4Line values for identical computations not followed by the same superscript symbol are signifi-




The effect of ~ietary inorganic sulfate and acetaminophen administration on the 
total 3 so
4
= uptake rat liver expressed as% dose (Experiment 2) 
Dietary 
Sulfate% 
.0002 (Diet A) 
.02 (Diet B) 
. 42 (Diet C) 
With 
cpm7mg 
dry liver wt. 
X 10-2 
35so~= Radio~ctivitv in 
Acet an;; nophen 1 
total cpm + 
wet l i vet wt. 
X 10-b 
19.0 ± 2.82,3,4a* 17.3 ± 3. o b* 
30.8 ± 6.3a* 
27.5 ± 4.3 a* 
28.6 ± 6. 3a* 
27.l ± 3_ 6ab* 
1Acetaminophen given 24 hours after Na2
35so;. 
2Data are means± SEM of 5 male rats. 
Dry Liver as Expressed 
Wfffiout 
cpm7mg 
dry liver wt. 
X 10-l'.'. 
a 32. 5 ± l . 6 
a* 30.8 ± 3.8 
a* 27.l ± 6.2 
by% Dose 
Acetaminophen 
t6fa-1 cprn + 
wet liver wt. 
X l o-6 
26.3 ± 2.4a 
a* 29. 5 ± 3. 6 
a* 26. l ± 5. 6 
3column values for identical computations not followed by the same superscript letter are signifi-
cantly different (P < 0.05). 
4Line values for identical computations not follm1Jed by the same superscript symbol are signifi-




difference in 35so4= occurs in the acetaminophen group when rats fed a 
diet containing 0.0002% level of inorganic sulfate plus methionine 
supplementation are compared to rats fed the 0.02% level of inorganic 
sulfate plus methionine diet. This difference is seen when data are 
expressed as total cpm + wet liver weight and cpm/mg +bodyweight with 
the control group fed the 0.02% level of inorganic sulfate plus methio-
nine, having the higher values. It should be noted that rats in 
experiment 2 were older and heavier than those in experiment l and in 
some cases may have been suffering from murine pneumonia. 
Experiment 3: 35s-Methionine Injected Simultaneously With Acetaminophen 
Administration 
The effects of dietary inorganic sulfate, varying methionine 
levels, and acetaminophen on liver 35S-glutathione, and 35s-cysteine 
synthesized from 35s-methionine and the recovery of 35s-methionine 
administered as a pulse dose are illustrated in Tables 9, 10, and 11 
respectively. No dietary or drug differences can be detected for 35s-
l t th . d 35s t . th . d f 35s th· . Th d g u a ,one an -cys e,ne syn es,ze rom -me 1on1ne. e ata 
in Table 11 expressing 35s-methionine in the liver show a significant 
difference in livers from rats treated with acetaminophen between those 
livers from rats fed a diet containing 0.02% level of inorganic sulfate 
with methionine supplementation and those fed a diet containing 0.0002% 
inorganic sulfate with methionine supplementation with the latter having 
higher values. This difference is seen when data are expressed as% 
dose, % dose+ liver weight, and% dose+ body weight. A statistically 
significant dietary difference is also detected in the livers from 
control groups when data are expressed as% dose and is between rats fed 
a diet containing 0.0002% inorganic sulfate with methionine 
TABLE 9 
The effect of dietary inorganic sulfate on liver 35 s-glutathione 
synthesized from 3~?-methionine after simultaneous 
administration of S-methionine and acetaminophen 
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Dietary 
Sulfate % With Acetaminophen Without Acetaminophen 
355 cpm in glutathione 
.0002 (Diet A)
1 % dose x 10- _5 % dose f liver wt. x 1g
6 % dose f body wt. x 10 
.02 (Diet B) -l 
% dose x 10 _5 % dose f liver wt. x 10 
% dose f body wt. x 10-6 
. 42 (Di et C) - l 
% dose x 10 _5 % dose f liver wt. x 10 
% dose f body wt. x 10-6 
2.97 ± l.36!';' 3a* 
2.64 ± 1.12 * 
1.28 ± .57a 
1.35 ± .35a: 
1.54 ± .40a * 
. 64 ± . 18a 
a * 2. 31 ± . 85 * 
2.62 ± 1 .05a * 
. 56 ± . 16a 
1Data are means± SEM of 5 male rats. 
3.46 a* ± 1.54a* 
3.53 ± l. 72 * 
3.42 ± 1. 81 a 
. 81 a* ± .24a* 
1. 01 ± .29 * 
.41 ± . 14 a 
2.31 a* ± .60a* 
1 .44 ± .48 * 
.64 ± 2ra • 0 
2column values for identical computations not followed by the 
same superscript letter are significantly different (P < 0.05). 
3Line values for identical computations not followed by the same 
superscript symbol are significantly different (P < 0.05). 
TABLE 10 
The effect of dietary inor~anic sulfate on liver 35s-cysteine 
synthesized from 3 S-methionine after simultaneous 
administration of 35s-methionine and acetaminophen 
Dietary 
37 
Sulfate% With Acetaminophen Without Acetaminophen 
35 S cpm 1 n cyste1ne 
.0002 (Diet Al 2 3.26:;2,3a* a* % dose x 10 _6 5.79 ± 15.23 ± 6.48a* 
% dose + 1 i v er wt. x 10 5.33 ± 2. 91 * 14. 43 ± 6.02 * 
% dose + body \'Jt. X 10-9 2.60 ± 1 .48a 3.54 ± 2. 18a 
.02 (Diet B) _2 a* a* % dose x 10 -6 .89 ± .23a* 3.00 ± 1. 33 ~* % dose+ 1 i ver wt. X 10
9 
.99 ± .24a* 4.03 ± 1. 70;* 
% dose + body wt. X 10- .40 ± . 10 l .62 ± . 15 
.42 (Diet C) _2 a* a* % dose x 10 
X 10-6 
3. 16 ± l.70a* . 61 ± . 14 a* 
% dose • liver wt. 3.66 ± l. 99 * .74 ± .22 * 
% dose+ body wt. X 10-9 l. 52 ± .82a .27 ± .08a 
1oata are means± SEM of 5 male rats. 
2column values for identical computations not followed by the 
same superscript letter are significantly different (P < 0.05). 
3Line values for identical computations not followed by the same 
superscript symbol are significantly different (P < 0.05). 
TABLE 11 
The effect of dietary inorganic sulfate on live35
35s-methionine 




Sulfate% With Acetaminophen Without Acetaminophen 
5s cpm in methionine 
.0002 (Diet A) 
1 371,2,3a* c* % dose x 10-3 8.53 ± 8.80 ± 1. 38a* 
% dose+ liver wt. x 1087 7.70 
. a * 
8.49 ± 1. 00 * ± 1. 32 * 
% dose+ body wt. x 10- 3.56 ± .57 a 3.90 ± .73a 
.02 (Diet B) _
3 4.32 ab* 4.00 d* % dose x 10 ± .88ab* ± .60a* 
% dose+ liver wt. x 10~7 4.94 ± 5.33ab* 5.33 ± 1. 22 a* 
% dose+ body wt. x 10- 2.01 ± .42 2.08 ± .43 
.42 (Diet C) 
3 b* d* % dose x 10-
-7 
6.00 ± 2.06b* 4.66 ± .69a* 
% dose • 1 i ver wt. x 1 Q8 6.60 ± 2.1\* 5.25 ± 1. 26 * % dose+ body Wt. X 10' 2.95 ± 1. 18 2.03 ± .25a 
1Data are means± SEM of 5 male rats. 
2column values for identical computations not followed by the 
same superscript letter are significantly different (P < 0.05). 
3Line values for identical computations not followed by the same 
superscript symbol are significantly different (P < 0.05). 
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supplementation and those fed 0.02% inorganic sulfate with methionine 
supplementation. A dietary difference is also seen between rats fed 
diets containing 0.0002% inorganic sulfate with methionine supplementa-
tion compared to rats fed the diet containing 0.42% inorganic sulfate 
without additional methionine. Rats fed 0.0002% inorganic sulfate with 
methionine supplementation have the higher 35s-methionine values in both 
comparisons. 
Experiment 4: 35s-Methionine Injected Three Hours Before Acetaminophen 
Administration 
The effects of dietary inorganic sulfate, varying levels of 
methionine, and acetaminophen on liver 35S-glutathione and liver 35s-
methionine, when acetaminophen was administered three hours after a 
pulse dose of 35s-methionine, are illustrated in Tables 12, 13, and 14, 
respectively. Dietary related statistically significant differences 
were detected for 35S-glutathione synthesized from 35s-methionine in 
livers of acetaminophen-treated animals. These differences are 
expressed as% dose,% dose f liver weight, and% dose f body weight 
when comparing livers from rats fed a diet containing 0.0002% inorganic 
sulfate plus methionine supplementation to those livers from rats fed 
diets containing 0.42% inorganic sulfate without methionine supplementa-
tion. Another dietary related statistically significant difference in 
the acetaminophen-treated rats can be observed in data from Table 14 on 
the recovery of 35s-methionine. A statistically significant higher 
value for 35s-methionine is observed in livers from rats fed diets con-
taining 0.0002% inorganic sulfate plus methionine supplementation and 
0.02% inorganic sulfate plus methionine supplementation to those livers 
from rats fed a diet containing 0.42% inorganic sulfate and no methionine 
TABLE 12 
The effect of dietary inorganic sulfate on liver 35 s-glutathione 
synthesized from 35s-methionine after administration of 
acetaminophen 3 hours after 35s-methionine injection 
Dietary 
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Sulfate% With Acetaminophen Without Acetaminophen 
-----------------::s5s cpm in glutathione 
. 0002 (Di et A) 
% dose x 10-l _5 % dose+ liver wt. x 10 
% dose+ body wt. x 10-7 
.02 (Diet B) -l 
% dose x 10 _5 % dose+ liver wt. x 10 
% dose+ body wt. x 10-7 
. 42 (Di et C) _ l 
% dose x 10 _5 % dose+ liver wt. x 10
7 % dose+ body wt. x 10-
5 82 ± 2 23 1,2,3a* . . a* 
2.50 ± .54 * 
11.52 ± 2.60a 
ab* 
10.50 ± 3.59ab* 
1 • 97 ± • 60 b* 
9.10 ± 3.31a 
b* 
4.69 ± l .81b* 
1.35 ± .24b* 
5.38 ± .79 
1oata are means± SEM of 5 male rats. 
a* 
6.35 ± 3.79a* 
l . 95 ± • 32 * 
9.02 ± .94a 
a* 
7.21 ± 3.60a* 
4.40 ± 2.93 * 
19.10 ± 5.63a 
a* 
4.61 ± 2.46a* 
2.72 ± 1.36a* 
11 . 10 ± 5. 56 
2column values for identical computations not followed by the 
same superscript letter are significantly different (P < 0.05). 
3Line values for identical computations not followed by the same 
superscript symbol are significantly different (P < 0.05). 
TABLE 13 
The effect of dietar~ inorganic sulfate on liver 35s-cysteine 
synthesized from 5s-rnethioni~i after administration of 
acetaminophen 3 hours after S-methionine injection 
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Dietary 
Sulfate% With Acetaminophen Without Acetaminophen 
--------------------"\5 S cpm in cystei ne 
.0002 (Diet A2 2 4.80 ± 2_571;2,3a* 9.22 a* % dose x 10 
X 10-6 
± 4.22a* 
% dose+ liver wt. 4. 19 ± a 7. 12 2.02a* ± 3. 10 a* 
% dose+ body wt. X 10-8 16.94 ± 9.10 31. 79 ± 13.74 
.02 (Diet B) _2 a* a* % dose x 10 12.43 ± 4.9la* 8.31 ± l. 95 a* 
% dose+ liver wt. x 10~6 10.10 ± 3.62 * 6.84 ± l. 18._* 
% dose 7 body wt. x 10- 47.63 ± 19.26a 25.34 ± 8.67° 
.42 (Diet C) _2 a* a* % dose x 10 -6 3.37 ± l. 34 a* 9. 41 ± 3.64a* 
% dose • liver Wt. X 10 2.67 ± .99 * 9. 13 ± 3.6la* 
% dose 7 body Wt. X 10-8 12. 16 ± 5.06a 37.33 ± 15.02 
l Data are means± SEM of 5 male rats. 
2column values for identical computations not followed by the 
same superscript letter are significantly different (P < 0.05). 
3Line values for identical computations not followed by the same 
superscript symbol are significantly different (P < 0.05). 
TABLE 14 
The effect of dietary inorganic sulfate on liver 35s-methionine 




Sulfate% ~~i th Acetaminophen Without Acetaminophen 
35 S cpm in methionine 
.0002 (Diet All 
2.401; 2 '3a* a* % dose x 10 
X 10-S 
11. 18 ± 7.56 ± 2. 10 a* 
0/ dose+ liver wt. 10.20 ± a 6.28 ± /0 2.39a* l . 83 a* 
% dose f body wt. X 10-8 3. 77 ± .64 2.93 ± .84 
. 02 (Di et B) _ l 
9.20 ± a* 8.82 a* % dose x 10 _5 .98a* ± l . 16 a* 
% dose+ liver wt. x 10 8. 12 ± l . 19 * 7.64 ± l. 05 * 
% dose+ body wt. x 10-8 3.55 ± .47a 3.30 ± .47a 
.42 (Diet C) -l b* a* 
% dose x 10 
X 10-5 
3.82 ± .78b* 4.96 ± .59a* 
% dose f liver wt. 3.64 ± .9lb* 4.50 ± .46 * 
% dose f body wt. X 10-8 1.40 ± .29 l.81 ± .2la 
1Data are means± SEM of 5 male rats. 
2column values for identical computations not followed by the 
same superscript letter are significantly different (P < 0.05). 
3Line values for identical computations not followed by the same 
superscript symbol are significantly different (P < 0.05). 
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supplementation. Dietary effects on 35s-cysteine synthesized from 35s-
methionine were not observed. In all of the data expressing radioactiv-
ity, no statistically significant differences were seen between acet-
aminophen-treated rats and controls. 
Experiment 5: 35s-Cysteine Injected Simultaneously With Acetaminophen 
Administration 
The effects of dietary inorganic sulfate, varying levels of 
methionine, and acetaminophen on the synthesis of 35s-glutathione from 
35s-cysteine and recovery of 35s-cysteine administered as a pulse dose 
are illustrated in Tables 15 and 16. Dietary effects on the synthesis 
of 35s-glutathione from 35s-cysteine (Table 15) in livers from rats fed diets 
containing 0.02% inorganic sulfate plus methionine supplementation are 
statistically difference from those livers from rats fed 0.42% inorganic 
sulfate with no methionine supplementation when data are expressed as 
% dose,% dose+ liver weight, and% dose+ body weight. In addition 
the livers from rats fed a diet containing 0.02% inorganic sulfate plus 
methionine supplementation are statistically difference from those rats 
fed 0.0002% inorganic sulfate plus methionine supplementation when data 
are expressed as% dose and% dose+ body weight. Dietary inorganic 
sulfate and methionine supplementation did not statistically affect 35s-
cysteine recovery (Tablel6). The effect of acetaminophen can be observed on 
the recovery of 35S-glutathione from 35s-cysteine when compared to controls 
(Table 15). Values for 35S-glutathione synthesized from 35s-cysteine in 
livers from rats fed a diet containing 0.02% inorganic sulfate plus 
methionine supplementation are higher for acetaminophen-treated rats 
than control rats when data are expressed as% dose, % dose+ liver 
weight, and% dose+ body weight. 
TABLE 15 
The effect of dietary inorganic sulfate on liver 35 s-glutathione 
synthesized from 3~5-cysteine after simultaneous administration of S-cysteine and acetaminophen 
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Dietary 
Sulfate% With Acetaminophen Without Acetaminophen 
-----------------355 cpm in glutathione 
.0002 (Diet All 
3.331,2,3!* a* % dose x 10 
X l 0- 5 
7.25 ± l. 91 ± .28a* 
% dose+ liver wt. 7.02 ± 2.95 a; b 2.56 ± .25 * 
% dose+ body wt. X 10-6 2.82 ± l. 30 a l. 13 ± . l oa 
.02 (Diet B) -l 
14. 01 b* 7.95 2.98a % dose x 10 _5 ± 3.1\* ± % dose+ liver wt. x 10 13. 12 ± 2.44b* 7.67 ± 2.84a 
% dose + body \1t. x l o-6 5. 19 ± 1.00 3.07 ± l. lOa 
.42 (Diet C) - l -* a* % dose x 10 
10-5 
5.49 ± l . 46;* 4. 31 ± l. 28a* 
% dose liver wt. X 5.43 ± l. 19 * 5.27 ± 2.00_* 
% dose+ body wt. X 10-6 2. 15 ± .59a l. 98 ± .53° 
l Data are means± SEM of 5 male rats. 
2column values for identical computations not followed by the 
same superscript letter are significantly different (P < 0.05). 
3Line values for identical computations not followed by the same 
superscript symbol are significantly different (P < 0.05). 
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TABLE 16 
The effect of dietary inorganic sulfate on liver 35 s-cysteine recovery 
after simultaneous administration of 35s-cysteine and acetaminophen 
Dietary 
Sulfate % With Acetaminophen Without Acetaminophen 
------------------355 cpm ,n cysterne 
.0002 (Diet A) 
± 2.961},3a* a* % dose x 10-2 _5 7. 14 6.47 ± 2.51 * 
% dose~ liver wt. x 10 7.51 ± 3.28:* 5.49 ± 2.03a* 
% dose~ body wt. x 20-7 2.82 ± 1. 19 2.40 ± .87a 
.02 (Diet B) _2 12.69 a* 13.87 a* % dose x 10 
X 10- 6 
± 3.78a* ± 3.49a* 
% dose -z- liver wt. 11. 72 ± 3.07 * 13.34 ± 3.26 * 
% dose -z- body wt. X 10-7 4.74 ± l . 31 a 5.55 ± 1. 40a 
.42 (Diet C) _2 a* a* % dose x 10 
10-6 
7.96 ± l. 40 a* 12.28 ± l .78 * 
% dose f liver wt. X 7.86 ± l. 40 * 14.29 ± 3.24a 
% dose -z- body wt. X 10-7 3.04 ± .60a 5.78 ± .55a 
1oata are means ± SEM of 5 male rats. 
2column values for identical computations not followed by the 
saLle superscript letter are significantly different (P < 0.05). 
3Line values for identical computations not followed by the same 
superscript symbol are significantly different (P < 0.05). 
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Recovery of 355-cysteine (Table 16) detects a statistically 
significant value for acetaminophen-treated rats, but no statistically 
significant values are seen as a result of dietary manipulations. The 
acetaminophen-treated rats fed a diet containing 0.42% inorganic sulfate 
with no additional methionine have a lower value for recovered 355-
cysteine expressed as% dose~ body weight when compared to controls. 
Experiment 6: 355-Cysteine Injected Three Hours After Acetaminophen 
Adm1nistrat1on 
The effects of dietary inorganic sulfate, varying levels of 
methionine, and acetaminophen on the synthesis of liver 355-glutathione 
from 355-cysteine and recovery of 355-cysteine when acetaminophen was 
administered three hours after 355-cysteine are illustrated in Tables 17 
and 18, respectively. Neither dietary inorganic sulfate level and vary-
ing levels of methionine supplementation nor did drug affect 355-gluta-
thione biosynthesis from 355-cysteine. The only effect of dietary sul-
fate level on recovered 355-cysteine (Table 18) was in the acetaminophen-
treated groups. When data are expressed as% dose, the liver 355-
cysteine value was higher from livers of rats fed a diet containing 
0.02% inorganic sulfate plus methionine supplementation than for those 
livers from rats fed a diet containing 0.42% inorganic sulfate with no 
additional methionine. No differences were observed between the 




The effect of dietary iQorganic sulfate on liver 35 S-glutathione 
synthesized from 3°s-cysteine after administration of 
acetaminophen 3 hours after 35s-cysteine injection 
Dietary 
Sulfate % With Acetaminophen Without Acetaminophen 
------------------355 cpm in glutathione 
.0002 (Diet A~ 
1.17 ± 0. rn1;2, 3a* 4.70 a* % dose x 10 -3 ± l . 85 a* % dose+ liver wt. X 10
5 
l. 28 ± 0. 24\ 3.44 ± .87 * 
% dose+ body wt. X 10- 4.97 ± 0.76a 19. 14 ± 7.70a 
.02 (Diet 8) l a* a* % dose x 10 
10:3 
3.06 ± l.23a* 8.97 ± 4.22a* 
% dose+ liver wt. X 4.27 ± l. 93 * 8.20 ± 3.30 * 
% dose+ body wt. X 10-~ 15.05 ± 6.39a 31. 14 ± 16.32a 
.42 (Diet C) l a* a* % dose x 10 
X 10-3 
.95 ± 0. 06 * 5.87 ± 2. 17a* 
% dose • liver wt. 1.04 ± 0. 70\ 6.75 ± 2.19a* 
% dose+ body wt. X 10-5 4.47 ± 0.4la 26. l 0 ± 9.29 
1Da"i:a are means ± SEM of 5 male rats. 
2column values for identical computations by the same superscript 
letter are significantly different (P < 0.05). 
3Line values for identical computations not followed by the same 
superscript symbol are significantly different (P < 0.05). 
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TABLE 18 
The effect of dietary inorganic sulfate on liver 35 s-cysteine recovery 
after administration of acetaminophen 3 hours after 35s-cysteine 
Dietary 
Sulfate% With Acetaminophen Without Acetaminophen 
------------------35S cpm in cystei ne 
.0002 (Diet A) 
1 72 l ,2,3ab* a* % dose _4 4.47 ± 1.83 ± .52a* . a * % dose+ liver wt. x 195 4.57 ± 1.96 * 1. 71 ± .52a* % dose f body wt. x 10 1.83 ± .70a .76 ± . 21 
.02 (Diet B) a * a* % dose _4 8.08 ± 2.76a * 5.55 ± 2. 77 a* % dose f liver wt. x 1Q5 9. 14 ± 3.37 * 4.92 ± 2.03 * % dose+ body wt. x 10 3.59 ± 1. 23a 2.17 ± 1 . 01 a 
.42 (Diet C) b* a* % dose -4 3.61 ± 1 . 40 a* 3.44 -+: 1 . 89 a* % dose+ liver wt. X 1 Q5 3.79 ± 1 .40 * 4.75 ± 2.99 * % dose+ body wt. X 10 1.62 ± .60a 1.60 ± .87a 
1Data are raeans ± SEJvi of 5 male rats. 
2colu~n values for identical computations not followed by the 
same superscript letter are significantly different (P < 0.05). 
3Line values for identical computations not followed by the same 
superscript symbol are significantly different (P < 0.05). 
CHAPTER V 
DISCUSSION 
The dietary importance of inorganic sulfate in the diet of the 
monogastric animal has been established in this laboratory (1). The 
importance of sulfur amino acids and inorganic sulfate in acetamino-
phen's :netabolism, treatment and protection from hepatotoxicity is well 
documented (16, 20, 21, 22, 25, 67). The relationships between sulfur 
amino acids and inorganic sulfate outlined in fig. 2, p. 10, indicate how many 
variables altering the sulfur amino acids can affect availability and/or 
demand for inorganic sulfate and therefore possibly affect the metabo-
lism of acetaminophen. Sodium 35so4= was administered to label ester 
sulfate, 35s-cysteine was administered to label ester sulfates and 
neutral sulfur compounds other than methionine, and 35s-methionine was 
administered to label ester sulfates, neutral sulfates, and--by a pre-
cursor relationship--give an indication of the effect acetaminophen may 
have on the remethylation pathway. By administering these iostopes with 
acetaminophen and in some experiments administering the isotopes prior 
to the drug, interrelationships of how acetaminophen would affect 
synthesis of sulfur containing compounds as well as affect tissue sulfur 
were investigated. The discussion, therefore, will be divided into 
three sections according to the labeled compound given the rats, i.e., 




In reviewing the data expressed as total liver sulfate as% body 
weight (Table 3, page 28), a statistically significant decrease in total 
liver sulfur as sulfate was observed in the lower values for total liver 
sulfur as sulfate in the acetaminophei;-treated groups when compared to the 
control groups in those rats fed diets containing 0.0002% and 0.02% inor-
ganic sulfate and additional methionine. Although a statistically signif-
icant difference cannot be seen in the 0.42% level of inorganic sulfate 
and no methionine supplementation, a lower total sulfur as sulfate value 
is seen in the drug-treated group. An additional observation from Table 3 
is that values for total liver sulfate as% body weight for acetaminophen-
treated rats show little variation between the different diets. These 
data suggest that in the acetaminophen-treated rats liver sulfate is 
lowered to some constant level at which sulfate conjugation becomes 
rate limiting. This interpretation of these data is in agreement with 
the suggestion by Wiertering et al. (14) that the Km for the formation 
of PAPS is high and that this high Km limits the amount of sulfation 
which can occur; therefore, high levels of acetaminophen will be 
glucuronidated or lead to the formation of N-acetyl-p-benzoquinone by the 
mixed function oxidase system in preference to conjugation with sulfate. 
In the control group fed the 0.42% level of inorganic sulfate 
with no additional methionine the total liver sulfate as% body weight 
is lower than in the group fed a diet containing 0.02% inorganic sulfate 
and methionine supplementation and significantly lower from the control 
group fed 0.0002% level of inorganic sulfate with methionine supplemen-
tation. These data suggest that the 0.42% inorganic sulfate diet not 
supplemented with methionine will cause an adverse effect on the rats' 
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total sulfur status. Smith8 in unpublished data demonstrated a similar 
phenomenon with respect to the level of inorganic sulfate in the liver 
of rats fed 0.0002, 0.02, 0. l, and 0.42% of inorganic sulfate with 
decreasing methionine supplementation as inorganic sulfate was increased 
to keep the total sulfur as sulfate constant at 0.67%. These data 
showea that those rats fed a diet containing 0.42% of inorganic sulfate 
and no methionine supplementation have decreased liver sulfate compared 
to those rats fed the diet containing 0. 1% of sulfate. Since Michels 
and Smith (5) had previously shown that inorganic sulfate is absorbed 
across the gastrointestinal tract, the decreased level and apparent 
availability of sulfate in the livers of rats fed those diets contain-
ing 0.42% of inorganic sulfate without additional methionine may reflect 
a limit in the liver's ability to extract sulfate from the portal sys-
tem. The 35so4= radiation values support Smith's theory (Tables 4 and 
5, pages 29 and 30). When 35so4= is expressed as cpm/mg x dry liver 
weight and total cpm ~ wet liver weights, rats treated with acetamino-
phen have significantly lower values for 35so4= when compared to 
control rats. 
The data in experiment 2--although internally inconsistent with 
those of experiment 1--differ in several respects to data in experi-
35 ment l. First, the rats in experiment 2 had been given the S-sulfate 
27 hours before sacrificing rather than 3 hours; secondly, they were 
older; and thirdly, some were expressing murine pneumonia which was not 
in remission. Therefore, since age, weight, and health affect drug 
metabolism, these data would not be expected to support those data in 
8John T. Smith (personal communication). 
which acetaminophen and 35so4= were given simultaneously (18, 22, 48, 
68). 
35s M th. . -1 e 1 onrne 
The data collected when rats are given 35s-~ethionine best 
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support earlier observations of Smith et al. that there is a sparing 
effect on methionine when rats are fed the optimal level (0.02%) of 
inorganic sulfate (7). In reviewing the values for 35S-glutathione 
synthesized from methionine, 35s-cysteine synthesized from methionine, 
and recovery of 35s-methionine in acetaminophen-treated rats fed the 
0.02% inorganic sulfate plus methionine, Tables 9, 10, and 11 on pages 
36, 37, and 38 respectively, one can note lower 35s-sulfur values 
compared to the diets lower and higher in organic sulfate. These lower 
35s-sulfur values for the acetaminophen-treated group, although not 
statistically significant, signify a trend which can be interpreted that 
the35s-sulfur is more available for detoxication purposes at this level. 
This assumption is supported by the values for 35S-glutathione and 35s-
cysteine synthesized from 35s-methionine given three hours prior to 
acetaminophen as seen in Tables 12 and 13, pages 40 and 41, respectively. 
Since this experiment was designed to evaluate acetaminophen's effect on 
tissue stores, the higher 35s-sulfur values of the livers from rats fed 
a diet containing 0.02% inorganic sulfate plus methionine indicate that 
the 35S-glutathione and 35s-cysteine synthesized from 35s-methionine were 
made more available for detoxication purposes than the other two diets. 
Table 10 on page 37 illustrating 35s-cysteine synthesized from 
35s-methionine, also reflects some information concerning the control 
rats fed a diet containing 0.42% inorganic sulfate with no additional 
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methionine. In rats fed the lower levels of inorganic sulfate plus 
methionine, acetaminophen-treated rats always have the lower values for 
35s-cysteine synthesized from 35s-methionine, whereas in rats fed a 
diet containing 0.42% inorganic sulfate with no additional methionine 
the values for 35S-glutathione synthesized from 35s-methionine are 
higher. Smith (l) earlier stated that sulfate could inhibit the conver-
sion of cysteine to sulfate. Taking this statement one step further, 
by sparing cysteine sulfate could have the potential to inhibit the con-
version of methionine to cysteine--thus accounting for the lower 35s 
activity in the cysteine isolated from the control group fed a diet 
containing 0.42% inorganic sulfate with no methionine supplementation. 
The trend higher values for 35s-cysteine synthesized from 35s-
methionine for the acetaminophen-treated group for the diet containing 
0.42% inorganic sulfate with no additional methionine indicate that the 
acetaminophen caused a stress which required that more 35s-methionine be 
used for synthesizing 35s-cysteine which is ultimately available for 
detoxifying acetaminophen. 
In comparing Tables 12, 13, and 14 on pages 40, 41, and 42 for 
values 35s-glutathione synthesized from 35s-methionine and recovery of 
35s-methionine, a trend is noted which would indicate that methionine is 
drawn out of the remethylation pathway when the drug is administered. 
Higher values for 35s-methionine in controls when rats were fed a diet 
containing 0.02% inorganic sulfate plus additional methionine and the 
subsequent high values for the recovered 35S-glutathione synthesized 
from methionine, and 35s-cysteine synthesized from methionine in the 
acetaminophen-treated rats fed on the 0.02% inorganic sulfate plus 
methionine diet illustrate 35s-methionine is being pulled out of the 
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remethylation pathway. In order words, more 35s-methionine is being 
incorporated into 35s-glutathione for detoxification purposes. The 
reason methionine would come out of the remethylation pathway is to 
provide the sulfur for GSH synthesis for acetaminophen detoxification. 
The higher values for 35s-methionine recovery (Table 14, page 42) in 
acetaminophen-treated rats suggest that rats which are fed diets con-
taining 0.0002%inorganic sulfate plus additional methionine and 0.02% 
inorganic sulfate with additional methionine keep more methionine in the 
liver for potential mobilization to GSH sulfur. 
A recent investigation by Smith9 supports the theory that methio-
nine is being drawn out of the remethylation pathway as well as an 
explanation why only trends are observable in several of the experiments 
in this investigation. After giving Sprague Dawley rats_ l- 14c-methionine, 
expired 14co2 was measured in simultaneous acetaminophen-treated and 
control groups for a period of two hours. An increased expiration of 
14co2 in the acetaminophen-treated rats when compared to the control 
rats was found. It addition, it was observed that this increased 14co2 
expiration as a result of drug treatment, is more apparent in the first 
hour of metabolism. Since the data reported here were collected three 
hours after drug administration, the most active portion of acetamino-
phen conjugation was missed and only a trend remained. 
35s-Cysteine 
The data collected from rats injected with 35s-cysteine give a 
clearer understanding of the effects of inorganic sulfate and methionine 
9John T. Smith (personal communication). 
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supplementation on the detoxication of acetaminophen. All four tables 
reflecting the metabolism of rats given 35s-cysteine (Tables 15, 16, 17, 
and 18 on pages 44, 45, 47, and 48) illustrate that those rats fed the 
optimal level of inorganic sulfate (0.02%) had greater 35s-activity in 
both cysteine recovered and glutathione synthesized than rats fed diets 
containing either of the other two levels of sulfate. The higher 
values for liver 35S-glutathione synthesized from 35s-cysteine shown in 
Table 15 on page 44 are very illustrative in showing the effect of diet 
and drug on sulfur metabolism. These higher 35S-glutathione values for 
glutathione synthesized from 35s-cysteine demonstrate that 35s-cysteine 
is needed for detoxification of acetaminophen and therefore is being 
pulled from the tissues for detoxication. The statistically significant 
values of 35S-glutathione synthesized from 35s-cysteine between rats 
treated with acetaminophen and controls are seen when rats are fed the 
diet containing 0.02% inorganic sulfate plus methionine as with the 
drug-treated group having the higher values. The same trend of high 
35s-cysteine values for livers from rats fed the diet containing 0.02% 
inorganic sulfate plus additional methionine is seen in the other livers 
of rats fed the other two diets when comparing acetaminophen-treated to 
controls. These statistically significant dietary differences manifest 
themselves when comparing rats fed a diet containing 0.0002% inorganic 
sulfate plus methionine and a diet containing 0.42% inorganic sulfate 
with no methionine supplementation to rats fed the optimal diet of 
0.02% inorganic sulfate plus additional methionine. This supports earlier 
evidence that 0.02% inorganic sulfate is the optimal level for the rat 
(7). These comparisons are statistically significant when comparing 
rats fed the diet containing 0.02% inorganic sulfate plus methionine 
supplementation, to the 0.0002% inorganic sulfate plus methionine 
supplementation when recovered 355-glutathione synthesized from 355-
methionine is expressed as% dose and% dose liver weight (Table 15, 
page 44) and when compared to rats fed 0.42% inorganic sulfate plus no 
methionine supplementation when recovered 355-glutathione synthesized 
from 355-methionine is expressed as% dose, ~%dose~ liver weight, 
and% dose~ body weight. 
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Table 15, page 44, illustrates the 355-glutathione values synthe-
sized from 355-cysteine after a simultaneous administration of 355-
cysteine and acetaminophen, and--as discussed previously--reflect 
statistically significant differences in regards to the effects of 
acetaminophen administration and varying levels of inorganic sulfate 
and methionine. Table 9, page 36, illustrates the values of liver 355-
glutathione synthesized from 355-methionine after a simultaneous injec-
tion of acetaminophen and shows no statistical significance regardless 
to drug treatment or the various diets. The reason values for 355-
glutathione synthesized from cysteine show significant differences with 
respect to drug administration and the various diets in comparison to 
the values of 355-glutathione synthesized from methionine is that 
cysteine is metabolically closer to G5H than methionine. Methionine 
compared to cysteine also has many more metabolic fates (fig. 2, page 
11 ) . 
Other useful information obtained was the fact that the time 
after the drug was administered to the time the liver was removed for 
analyzing was possibly too long of a time period to measure the effects 
which acetaminophen may have on sulfur metabolism. Since in some 
experiments only trends were seen, an earlier sacrificing time could 
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yield more evidence to further support the importance of inorganic 
sulfur and sulfur sources in the detoxication of acetaminophen. Further 
research is warranted in this area. 
CHAPTER VI 
SUMMARY 
The interrelationship between methionine and inorganic sulfate 
affecting availability and/or demand for sulfur nucleophiles needed for 
detoxicating acetaminophen was investigated. A pulse dose of 7 µCi of 
35so4= was administered to label ester sulfates and livers were analyzed 
for total liver sulfur as sulfate and radioactivity. A pulse dose of 
7 µCi of 35s-cysteine was administered to label 35S-glutathione synthe-
sized from 35s-cysteine as well as the recovery of 35s-cysteine. To 
evaluate the effect acetaminophen and varying levels of inorganic 
sulfate and methionine may have on 35s-methionine being drawn from the 
remethylation pathway, a pulse dose of 7 µCi of 35s-methionine was 
. . . t d B d . . t . 35s th. . 35s 1 t -1--h. d aamrn,s ere . ya minis er,ng -me ,onrne, -g u a"' ,,one, an 
35s t · th . . f 35s th' . 11 th -cys e1ne syn es1zect rom -me 1on1ne as we as e recovery 
of 35s-methionine was determined. These isotopes were administered in 
certain experiments simultaneously with acetaminophen (75 mg acetamino-
phen/kg body weight); the rats were sacrificed three hours later to 
evaluate the effect on liver synthesis of sulfur compounds. The isotopes 
were also administered prior to acetaminophen administration to ascer-
tain the effect acetaminophen would have on tissue sulfur compounds. 
S .. 35so = . 24 h . t . . h d 35s oa,um 4 was given ours prior o acetam,nop en an -
methionine and 35s-cysteine three hours prior to acetaminophen adminis-
tration. 
35 = The data from the rats given so4 simultaneously with acetamino-
phen indicate that in the acetaminophen-treated rats, liver sulfate is 
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lowered to some constant level at which sulfate conjugation becomes 
rate limiting. The data also suggest that high levels of acetaminophen 
will be glucuronidated or metabolized by P-450 enzymes in preference to 
conjugation with sulfate. 
Data from rats given 35s-methionine indicate that there is an 
increased need for cysteine and that since sulfate can spare the conver-
sion of cysteine sulfur to sulfate it could also spare the conversion of 
35s-methionine to 35s-cysteine. There is an indication of a trend that 
35s th· . b 11 d f th th l t· t 1 t f -me 1on1ne may e pu e rom e reme ya 10n pa nway o orm 
35s-glutathione thus facilitating acetaminophen detoxification. Data also 
support previous researchers who demonstrated that 0.02% of tnorganic 
sulfate is the optimal level for the diet of the monogastric animal. 
The data collected from livers of rats given the pulse dose of 
35s-cysteine supply evidence that cysteine is being pulled from tissue 
stores for detoxication of acetaminophen. This investigation stresses 
the importance of dietary inorganic sulfate as well as methionine in 
detoxification of a pulse dose of acetaminophen. 
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